Tune into our webinars for subject matter expertise on a variety of key topics.

Upcoming Webinars:

Sorry, no upcoming webinars. Check later for updates.

Previous / On-Demand Webinars:

OCT Evaluation of Neovascular AMD in Clinical Trials:
A Reading Center Perspective 
Feb 22, 2024 | 11 AM EST
Duration: 45 Minutes

This presentation will give the audience an overview of the role a reading center plays in the use of Optical Coherence Tomography (OCT) in major studies for patients with neovascular Age-related Macular Degeneration (nAMD).

Navigating Neuro-Oncology: Understanding Pseudoprogression and Harnessing PsP Outcomes for Optimal Imaging Assessment
Nov 15, 2023 | 5:30 PM ET
Duration: 45 Minutes

Most brain cancer diagnoses in the United States are glioma, and our upcoming webinar will explore the challenges and potential solutions for assessing these tumors.

AI Integration in Radiology Clinical Practice
Jun 21, 2023 | 11 AM CST
Duration: 45 Minutes

Webinar key points: AI Market Space Overview, How to Choose an AI Solution that Best Fits Your Clinical Practice, Challenges and Opportunities of AI Integration in Radiology Clinical Practice

Validating Your Imaging Data to Secure Funding
May 24, 2023 | 11 AM CST
Duration: 45 Minutes

This will be an interactive Q/A style session discussing how early phase centralized image storage can help you secure funding.

Reader Challenges in Blinded Independent Central Reviews
May 10, 2023 | 11 AM CST
Duration: 45 Minutes

Dr. Smalberg will define what a central reviewer is and discuss challenges and opportunities involved in interactions with imaging core labs and/or sponsors.

Lugano and Oncology Imaging Endpoints
Feb 22, 2023 | 11 AM EST
Duration: 45 Minutes

 Learn about the fundamentals of Lugano Classification, data collection, and recent academia and industry recommendations on challenges of assessment.

PCWG3 (Prostate Cancer Working Group 3) and Oncology Imaging Endpoints
Jan 18, 2023 | 11 AM EST
Duration: 45 Minutes

Prostate cancer is one of the most common cancer types in men. With bone as a frequent metastatic site, response assessments for prostate cancer have additional considerations beyond RECIST 1.1.

Fundamentals of iRECIST and Imaging Endpoints
Nov 16, 2022 | 11 AM EST
Duration: 45 Minutes

iRECIST provides guidance for solid tumor response criteria in immunotherapy to accommodate possible pseudoprogression, which may occur in some subjects. In this presentation, MERIT will discuss the rules and principles of iRECIST, imaging endpoints, and special considerations for using iRECIST response criteria.

Take Control of Your Clinical Trial:
How an Imaging Core Lab Can Help Overcome Common Study Challenges
Oct 12, 2022 | 11 AM EST
Duration: 45 Minutes

Does your oncology clinical trial have an imaging component? Are you new to working with imaging core labs? An imaging core lab can provide your team with resources, knowledge, and experience that can help make your study a success.

RANO and Oncology Trial Endpoints
Sep 14, 2022 | 11 AM EST
Duration: 45 Minutes

The Response Assessment in Neuro-Oncology (RANO) group provides various central nervous system-related tumor response criteria and guidance for assessments. In this webinar, MERIT will discuss the principles and recommendations of RANO response criteria for high grade glioma (HGG) and the imaging endpoint information that needs to be collected for clinical trials.

RECIST 1.1 and Oncology Trial Endpoints
Aug 11, 2022 | 11 AM EST
Duration: 45 Minutes

RECIST 1.1 is the standard response criteria for solid tumors and has been a basis for adaptation and variation of other response criteria such as mRECIST, irRECIST, iRECIST, and so on. In this on-demand webinar recording, MERIT discusses the principles of RECIST 1.1, the information needed to collect imaging endpoints, and special considerations while using the RECIST 1.1 criteria.


Gain assurance with our proven track record providing reliable endpoint expertise to 12 of the top 20 global pharmaceutical companies

Reap the benefits of competitive pricing and shortened timelines resulting from efficiencies gained over decades of experience

Benefit from transparent communication and prompt access to in-house experts

Reduce clinical trial risk. Our experienced team delivers risk management by anticipating your study challenges

Increase your trial’s flexibility with our scalable solutions. We adapt quickly to your changing needs

Rely on MERIT consistently meeting customer and regulatory requirements as validated through our ISO 27001 and ISO 13485 certifications

Enhance the efficiency and accuracy of your imaging data collection and analysis with EXCELSIORTM, our cloud-based software solution

Simplify and streamline your pulmonary clinical trial process with CompleClinical®, MERIT’s innovative spirometry software application

Some companies tend to overpromise and underdeliver, which puts your study success at risk. If you’re looking for a clinical trial endpoint services provider that will value your partnership and make your study a priority, consider MERIT.



Our Partners



Connect with us to learn more about how our expertise and approach can support bringing your product to market on-time and on-budget. Your success is our priority.